070 – BioXcel Leverages AI to Tackle Disease! Cassava’s PTI-125 has a Suspicious Coincidence

BioXcel (#BTAI) is a clinical-stage biotechnology company looking to commercialize neuroscience and oncology products developed with the help of their unique AI technology. I go through the data they have seen to date and upcoming catalysts that are likely to significantly affect the stock in the short term. As well, I touch on Cassava Sciences’ […]